Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

FLGT Fulgent Genetics Inc

0.26 (1.33%)
After Hours
Last Updated: 16:01:10
Delayed by 15 minutes


Draw Mode:

Volume 168,687
Bid Price 19.40
Ask Price 20.00
News -
Day High 19.82


52 Week Range


Day Low 19.2023
Company Name Stock Ticker Symbol Market Type
Fulgent Genetics Inc FLGT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.26 1.33% 19.78 16:01:10
Open Price Low Price High Price Close Price Prev Close
19.46 19.2023 19.82 19.78 19.52
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,518 168,687 $ 19.62 $ 3,310,013 - 18.91 - 44.09
Last Trade Time Type Quantity Stock Price Currency
16:18:20 14 $ 19.78 USD

Fulgent Genetics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
589.14M 29.78M - 289.21M -167.83M -5.63 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Fulgent Genetics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No FLGT Message Board. Create One! See More Posts on FLGT Message Board See More Message Board Posts

Historical FLGT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week20.1620.5018.9119.51139,296-0.38-1.88%
1 Month21.6421.7118.9120.54128,717-1.86-8.60%
3 Months22.2322.9118.9121.00154,105-2.45-11.02%
6 Months28.0930.6818.9123.54186,538-8.31-29.58%
1 Year37.3444.0918.9127.34203,626-17.56-47.03%
3 Years74.8822112.0018.9157.59325,478-55.10-73.59%
5 Years5.77189.88995.2559.40513,51014.01242.81%

Fulgent Genetics Description

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Your Recent History

Delayed Upgrade Clock